Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-03-16
- Last Posted Date
- 2015-09-01
- Lead Sponsor
- Astellas Pharma Global Development, Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT01555866
- Locations
- 🇺🇸
DaVita Research, Denver, Colorado, United States
🇺🇸DaVita Clinical Research, Minneapolis, Minnesota, United States
🇺🇸Clinical Pharmacology Miami, Miami, Florida, United States
A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-02-09
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Astellas Pharma Global Development, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT01529684
- Locations
- 🇺🇸
Northwest Medical Specialties, PLLC, Tacoma, Washington, United States
🇺🇸Comprehensive Clinical Development NW, Inc., Tacoma, Washington, United States
Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2008-12-30
- Last Posted Date
- 2015-11-04
- Lead Sponsor
- Astellas Pharma Global Development, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT00815516
- Locations
- 🇷🇴
Emergency County Clinical Hospital, Cluj-Napoca, Romania
🇺🇸WakeMed Health and Hospitals, Raleigh, North Carolina, United States
🇺🇸Children's Hospital of Orange County, Orange, California, United States
© Copyright 2024. All Rights Reserved by MedPath